MENCAINE- lidocaine, menthol patch Verenigde Staten - Engels - NLM (National Library of Medicine)

mencaine- lidocaine, menthol patch

terrain pharmaceuticals - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - lidocaine 4.5 mg in 100 mg - uses: temporarily relieves mild to moderate aches and pains of muscles and joints associated with: - muscle soreness - strains - sprains - arthritis - simple backache - muscle stiffness - bruises instructions for use: - clean and dry affected area - open pouch and remove one patch - remove protective film from patch - apply one patch to the affected area of pain and leave in place for 8 to 12 hours - if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours - only use one patch at a time - do not use more than 2 patches per day - wash hands with soup and water after applying or removing patch - reseal pouch containing unused patches immediately after each use

READYSHARP-K- lidocaine hydrochloride, bupivacaine hydrochloride, and triamcinolone acetonide Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp-k- lidocaine hydrochloride, bupivacaine hydrochloride, and triamcinolone acetonide

terrain pharmaceuticals - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 40 mg in 1 ml - where oral therapy is not feasible, injectable corticosteroid therapy, including kenalog-40 injection (triamcinolone acetonide injectable suspension, usp) is indicated for intramuscular use as follows: allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer,

READYSHARP TRIAMCINOLONE acetonide injection solution Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp triamcinolone acetonide injection solution

terrain pharmaceuticals - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 40 mg in 1 ml

READYSHARP METHYLPREDNISOLONE 80 acetate injection suspension Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp methylprednisolone 80 acetate injection suspension

terrain pharmaceuticals - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 80 mg in 1 ml

READYSHARP BUPIVACAINE hydrochloride injection solution Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp bupivacaine hydrochloride injection solution

terrain pharmaceuticals - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride anhydrous 5 mg in 1 ml

DICLOCAINE- lidocaine 4.5%, diclofenac 1.25% patch Verenigde Staten - Engels - NLM (National Library of Medicine)

diclocaine- lidocaine 4.5%, diclofenac 1.25% patch

terrain pharmaceuticals - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - uses: temporarily relieves mild to moderate aches and pains of muscles and joints associated with: - muscle soreness - strains - sprains - arthritis - simple backache - muscle stiffness - bruises instructions for use: - clean and dry affected area - open pouch and remove one patch - remove protective film from patch - apply one patch to the affected area of pain and leave in place for 8 to 12 hours - if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours - only use one patch at a time - do not use more than 2 patches per day - wash hands with soup and water after applying or removing patch - reseal pouch containing unused patches immediately after each use

PRE AND POST SX POUCH- mupirocin 2%, dimethicone 5%, chlorhexidine gluconate 4% kit Verenigde Staten - Engels - NLM (National Library of Medicine)

pre and post sx pouch- mupirocin 2%, dimethicone 5%, chlorhexidine gluconate 4% kit

terrain pharmaceuticals - mupirocin (unii: d0gx863oa5) (mupirocin - unii:d0gx863oa5) - chlorhexidine gluconate 4 g in 100 ml - mupirocin ointment usp, 2% is indicated for the topical treatment of impetigo due to: s. aureus and s. pyogenes . this drug is contraindicated in patients with known hypersensitivity to any of the constituents of the product.

READYSHARP ANESTHETICS PLUS METHYLPREDNISOLONE 80- lidocaine hydrochloride, bupivacaine hydrochloride, and methylprednisolone ac Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp anesthetics plus methylprednisolone 80- lidocaine hydrochloride, bupivacaine hydrochloride, and methylprednisolone ac

terrain pharmaceuticals - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 80 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. marcaine is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recomm

READYSHARP ANESTHETICS PLUS BETAMETHASONE- lidocaine hydrochloride, bupivacaine hydrochloride, and betamethasone sodium phosphat Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp anesthetics plus betamethasone- lidocaine hydrochloride, bupivacaine hydrochloride, and betamethasone sodium phosphat

terrain pharmaceuticals - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. marcaine is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recomm

READYSHARP-A- lidocaine hydrochloride and bupivacaine hydrochloride kit Verenigde Staten - Engels - NLM (National Library of Medicine)

readysharp-a- lidocaine hydrochloride and bupivacaine hydrochloride kit

terrain pharmaceuticals - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. marcaine is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recomm